Differences in Coagulation Test Kits

The aim of this study is to assess the effect of Innovin® reagent on laboratory results when compared with the Thromborel® S.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Effect of Different Reagents. Oral Anticoagulant Therapy

Sex eligibility

All sexes

Study type

Observational

Primary location

Turkiye Yuksek Ihtisas Hospital

Ankara, 06100, Turkey (Türkiye)

About this study

Thromboplastins are the screening tests which are used in the diagnosis of acquired or inherited disorders of the coagulation system but still, alterations between various thromboplastin preparations in the measurements remains a problem.Blood samples are going to drawn from patients receiving and not receiving oral anticoagulant therapy (OAT) during their routine laboratory tests. Samples are subjected to analysis by using Thromborel® S and Innovin® reagents. Mean International Normalized Ratio (INR), prothrombin time and fibrinogen values are going to compared. To further study the importance of this phenomenon the cohort will be divided into three subgroups according to the INR values as Group I: Patients not receiving OAT, Group II: Patients under OAT and INR values in good therapeutic range and Group III: Patients under OAT and INR values over the therapeutic range.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Routine control patients receiving and not receiving oral anticoagulant therapy

Exclusion criteria

Hemolytic and/or lipemic samples were excluded.

Sponsors and collaborators

Lead sponsor

Yuksek Ihtisas Hospital

Other

Registry information

Official study title

The Effects of Different Reagents on Coagulation Tests: Innovin Versus Thromborel-S.

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Apr 23, 2010
Registry last updated: Apr 23, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed